NCT02630121View on ClinicalTrials.gov

Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

PHASE4RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Sleep ApneaChronic Nasal Congestion
Interventions
DRUG

Oxymetazoline Hydrochloride

Proportion of the subjects with 50% reduction in AHI.

DRUG

Placebo

Proportion of the subjects with 50% reduction in AHI.

Trial Locations (1)

33613

RECRUITING

Usf Asthma Allergy and Immunology Cru, Tampa

All Listed Sponsors
lead

University of South Florida

OTHER